NCT00362635View on ClinicalTrials.gov

Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2011

Conditions
Hepatitis B
Interventions
DRUG

Clevudine

Trial Locations (2)

Unknown

Alice Ho Miu Ling Nethersole Hospital, Tai Po

Queen Mary Hospital, Road

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY

NCT00362635 - Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection | Biotech Hunter | Biotech Hunter